Position history for BlackRock, Inc.'s holdings in LEXEO THERAPEUTICS INC
BlackRock, Inc. holds 4.9M shares of LXEO (LEXEO THERAPEUTICS INC), worth $48.7M as of 2025-Q4. The position was increased (++126.0% shares). LXEO represents 0.0% of BlackRock, Inc.'s portfolio.
Current Value
$48.7M
Current Shares
4.9M
Total Value Change
+$36.7M
Total Shares Change
+3.1M
Other major holders of LXEO: JANUS HENDERSON GROUP PLC, RA CAPITAL MANAGEMENT, L.P., ADAGE CAPITAL PARTNERS GP, L.L.C., CITADEL ADVISORS LLC
Increased |
| 4.9M |
+126.0% |
| $48.7M |
| 0.0% |
| $9.74 |
47 |
| 2025-Q3 | Increased | 2.2M | +18.8% | $14.4M | 0.0% | $6.66 | 33 |
| 2025-Q2 | Decreased | 1.8M | -0.8% | $7.3M | 0.0% | $4.12 | 0 |
| 2025-Q1 | Increased | 1.8M | +1.1% | $6.4M | 0.0% | $4.10 | 27 |
| 2024-Q4 | New | 1.8M | - | $12M | 0.0% | $6.54 | 39 |